We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Home Bancorp
HBCP
$566M
| $698K | ﹤0.01% |
26,094
-882
| -3% | -$21.6K |
|
2777
Abeona Therapeutics
ABEO
$413M
| $697K | ﹤0.01% |
9,571
-9,714
| -50% | -$671K |
|
|
ATXS
2778
DELISTED
Astria Therapeutics
ATXS
| $697K | ﹤0.01% |
+18,061
| New | +$643K |
|
|
SMMF
2779
DELISTED
Summit Financial Group, Inc.
SMMF
| $695K | ﹤0.01% |
42,155
+1,472
| +4% | +$24.2K |
|
2780
Digimarc Corp
DMRC
$178M
| $691K | ﹤0.01% |
43,247
| – | – |
|
2781
RPC Inc
RES
$1.3B
| $691K | ﹤0.01% |
224,301
-3,532
| -2% | -$10.8K |
|
|
HMTV
2782
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $690K | ﹤0.01% |
70,267
+2,871
| +4% | +$26.2K |
|
|
KZR
2783
DELISTED
Kezar Life Sciences
KZR
| $689K | ﹤0.01% |
13,301
+2,173
| +20% | +$110K |
|
2784
Alphatec Holdings
ATEC
$1.44B
| $687K | ﹤0.01% |
146,033
-26,048
| -15% | -$115K |
|
2785
National Bankshares
NKSH
$268M
| $685K | ﹤0.01% |
23,940
-1,692
| -7% | -$49.2K |
|
2786
Hurco Companies Inc
HURC
$143M
| $678K | ﹤0.01% |
24,233
-34
| -0.1% | -$997 |
|
|
SIEN
2787
DELISTED
Sientra, Inc.
SIEN
| $678K | ﹤0.01% |
17,497
-25,069
| -59% | -$756K |
|
2788
Apyx Medical
APYX
$171M
| $676K | ﹤0.01% |
121,881
+33,954
| +39% | +$141K |
|
2789
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $675K | ﹤0.01% |
14,458
| – | – |
|
|
EEX
2790
DELISTED
Emerald Holding
EEX
| $669K | ﹤0.01% |
217,430
-11,308
| -5% | -$26.8K |
|
2791
Cato Corp
CATO
$66.1M
| $664K | ﹤0.01% |
81,079
-2,923
| -3% | -$28.8K |
|
|
GNTY
2792
DELISTED
Guaranty Bancshares
GNTY
| $663K | ﹤0.01% |
28,232
-117
| -0.4% | -$2.64K |
|
|
BFIN
2793
DELISTED
BankFinancial
BFIN
| $659K | ﹤0.01% |
78,523
-28,331
| -27% | -$227K |
|
|
PRTK
2794
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $659K | ﹤0.01% |
126,235
-67,222
| -35% | -$299K |
|
2795
OptimizeRx
OPRX
$133M
| $656K | ﹤0.01% |
50,341
+8,245
| +20% | +$89.6K |
|
2796
Stereotaxis
STXS
$141M
| $656K | ﹤0.01% |
+147,034
| New | +$595K |
|
2797
LCNB Corp
LCNB
$283M
| $655K | ﹤0.01% |
41,020
-131
| -0.3% | -$1.8K |
|
2798
MetroCity Bankshares
MCBS
$1.03B
| $655K | ﹤0.01% |
45,717
+5,691
| +14% | +$64.5K |
|
2799
United States Lime & Minerals
USLM
$3.44B
| $651K | ﹤0.01% |
38,575
-2,310
| -6% | -$36K |
|
|
ENZ
2800
DELISTED
Enzo Biochem, Inc.
ENZ
| $644K | ﹤0.01% |
287,582
+119,095
| +71% | +$306K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.